Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Van Pelt

Showing results (41-50 of 46) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 46 results.
Annals of the Rheumatic Diseases|June 26, 2012
Effectiveness and safety of a second and third biological agent after failing etanercept in juvenile idiopathic arthritis: results from the Dutch National ABC RegisterMarieke H Otten, Femke H M Prince, Janneke Anink, et al.
The Review of Scientific Instruments|February 11, 2024
Robust unfolding of MeV x-ray spectra from filter stack spectrometer dataC-S Wong, J Strehlow, D P Broughton, et al.
Annals of the Rheumatic Diseases|March 20, 2014
Trends in prescription of biological agents and outcomes of juvenile idiopathic arthritis: results of the Dutch national Arthritis and Biologics in Children RegisterMarieke H Otten, Janneke Anink, Femke H M Prince, et al.
Journal of Human Immunity|February 12, 2026
Human TBK1 deficiency: An expanded spectrum from autoinflammation to viral encephalitisYemsratch Akalu, Justin Taft, Thomas Berger, et al.
Rheumatology (Oxford, England)|June 7, 2013
Treatment choices of paediatric rheumatologists for juvenile idiopathic arthritis: etanercept or adalimumab?Janneke Anink, Marieke H Otten, Simone L Gorter, et al.
The New Phytologist|October 5, 2016
Genetic architecture of plant stress resistance: multi-trait genome-wide association mappingManus P M Thoen, Nelson H Davila Olivas, Karen J Kloth, et al.
Pageof 5

Showing results (41-50 of 46) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 46 results.
Annals of the Rheumatic Diseases|June 26, 2012
Effectiveness and safety of a second and third biological agent after failing etanercept in juvenile idiopathic arthritis: results from the Dutch National ABC RegisterMarieke H Otten, Femke H M Prince, Janneke Anink, et al.
The Review of Scientific Instruments|February 11, 2024
Robust unfolding of MeV x-ray spectra from filter stack spectrometer dataC-S Wong, J Strehlow, D P Broughton, et al.
Annals of the Rheumatic Diseases|March 20, 2014
Trends in prescription of biological agents and outcomes of juvenile idiopathic arthritis: results of the Dutch national Arthritis and Biologics in Children RegisterMarieke H Otten, Janneke Anink, Femke H M Prince, et al.
Journal of Human Immunity|February 12, 2026
Human TBK1 deficiency: An expanded spectrum from autoinflammation to viral encephalitisYemsratch Akalu, Justin Taft, Thomas Berger, et al.
Rheumatology (Oxford, England)|June 7, 2013
Treatment choices of paediatric rheumatologists for juvenile idiopathic arthritis: etanercept or adalimumab?Janneke Anink, Marieke H Otten, Simone L Gorter, et al.
The New Phytologist|October 5, 2016
Genetic architecture of plant stress resistance: multi-trait genome-wide association mappingManus P M Thoen, Nelson H Davila Olivas, Karen J Kloth, et al.
Pageof 5